Join Plastic Surgery Practice Co-Chief Editors Alison Werner and Keri Stephens as they talk to ELEVAI Labs Founder and CEO Jordan Plews, PhD, to talk about the company's ELEVAI E-series post-procedure aftercare products featuring a proprietary exosome technology. ELEVAI Labs is a biotechnology company developing regenerative skincare applications. The company is focused on physician-dispensed products that can work to support patient skin health following a range of procedures, from microneedling to laser resurfacing. Plews, who has a background in biochemical engineering, shares how his work in stem cell research related to regenerative medicine brought him to aesthetics. He developed a proprietary technology centered around exosomes and the role they play in the cellular repair process of the skin. These exosomes are ultra-small, nanoparticle compartments packed with growth factors known to support skin health. The proprietary ELEVAI Exosomes are the key ingredient in the company’s post-treatment aftercare system, the ELEVAI E-series, launched in 2021, which includes ELEVAI empower and ELEVAI infinity. In this episode, Plews not only provides a deep dive into how exosomes in skin care work, but also explains how the ELEVAI E-series products can be used for post-treatment aftercare for procedures including microneedling to laser resurfacing. As he says, these products work well where “you’re causing a low level of damage and you want to give the patient something that’s going to really supercharge their recovery.” ELEVAI empower is a concentrated serum, designed specifically for single-use in office application post-procedure. ELEVAI enfinity is a daily serum that can then be sent home with the patient to support their skin health post procedure. According to ELEVAI, both products aim to help activate the skin’s natural healing process; reduce the appearance of fine lines and wrinkles; improve the appearance of uneven skin tone, skin texture, and laxity; and reduce the appearance of pigmentation and redness. This podcast episode sees Plews talk about the ingredients in these post-procedure aftercare products that work with the ELEVAI Exosome technology, and what both plastics surgeons, their staff, and patients can expect with use. He also explains why these products are only available for sale from authorized providers, for instance, physicians and their trained staff, and why it is important for ELEVAI to work with plastic surgeons and staff like this. PSP
The MEDQOR Podcast Network provides insights, reporting and analysis on MedTech Innovation across all of healthcare. We’re supported by ten leading brands in healthcare, whose chief editors will join us on a recurring basis to talk with key leaders in their industries about what’s happening now.
MEDQOR provides healthcare business intelligence to help MedTech and Pharma professionals connect and stay abreast of the advancing technologies to drive improved patient outcomes. We help healthcare innovators engage their market to bring new technology into hospitals, clinics and offices to improve and streamline patient care.
Thanks for listening as we discuss technology and treatment trends ranging from clear aligner therapy all the way to MRI machines and lab automation equipment. If you enjoy what you hear, please like, subscribe and share.
Dr Jordan
Enterprise
Resources
Resource Library
Webinars, Ebooks, and more
Help Center
Find the help you need
Developers
Easy-to-use Rev API documentation
Create an Account
×
Why Rev?
Why Rev?
Pricing
Customers
Services
Human Transcription
Automated Transcription
English Captions
Global Subtitles
Live Captions for Zoom
Speech-to-Text APIs
Developers
Resources
Ebooks & Webinars
How-to Guides
Blog
Get Started